Matt Hewitt
Stock Analyst at Craig-Hallum
(3.30)
# 2,413
Out of 4,574 analysts
793
Total ratings
45.3%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Downgraded: Hold | $31 | $29.98 | +3.40% | 35 | Jul 22, 2026 | |
| CDXS Codexis | Maintained: Buy | n/a | $1.48 | - | 51 | Jul 17, 2026 | |
| DYAI Dyadic International | Maintained: Buy | n/a | $1.19 | - | 13 | Jul 16, 2026 | |
| OABI OmniAb | Maintained: Buy | n/a | $2.03 | - | 28 | Jul 16, 2026 | |
| CYRX Cryoport | Maintained: Buy | n/a | $15.37 | - | 8 | Jul 15, 2026 | |
| BHST BioHarvest Sciences | Maintained: Buy | n/a | $1.92 | - | 19 | Jul 15, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | n/a | $300.53 | - | 70 | Jul 13, 2026 | |
| SLP Simulations Plus | Rated: Hold | n/a | $18.34 | - | 53 | Jul 8, 2026 | |
| SDGR Schrödinger | Maintained: Buy | n/a | $14.97 | - | 52 | Jul 8, 2026 | |
| CERT Certara | Rated: Hold | n/a | $7.51 | - | 17 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.33 | - | 39 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.08 | - | 36 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $131.96 | - | 57 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.97 | - | 21 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $41.00 | - | 48 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.99 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.77 | - | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.12 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.92 | +53.06% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $6.76 | -26.04% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $27.14 | +47.41% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.9035 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $101.25 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.13 | +95.76% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.29 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.32 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.24 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.89 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.96 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.34 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.97 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $3.03 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.78 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.77 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $13.59 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $71.60 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.20 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $78.78 | n/a | 1 | Nov 8, 2017 |
BioLife Solutions
Jul 22, 2026
Downgraded: Hold
Price Target: $31
Current: $29.98
Upside: +3.40%
Codexis
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $1.48
Upside: -
Dyadic International
Jul 16, 2026
Maintained: Buy
Price Target: n/a
Current: $1.19
Upside: -
OmniAb
Jul 16, 2026
Maintained: Buy
Price Target: n/a
Current: $2.03
Upside: -
Cryoport
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $15.37
Upside: -
BioHarvest Sciences
Jul 15, 2026
Maintained: Buy
Price Target: n/a
Current: $1.92
Upside: -
Ligand Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: n/a
Current: $300.53
Upside: -
Simulations Plus
Jul 8, 2026
Rated: Hold
Price Target: n/a
Current: $18.34
Upside: -
Schrödinger
Jul 8, 2026
Maintained: Buy
Price Target: n/a
Current: $14.97
Upside: -
Certara
Jul 8, 2026
Rated: Hold
Price Target: n/a
Current: $7.51
Upside: -
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.33
Upside: -
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.08
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $131.96
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $4.97
Upside: -
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $41.00
Upside: -
Jun 2, 2026
Maintained: Hold
Price Target: n/a
Current: $4.99
Upside: -
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $18.77
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $9.12
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $3.92
Upside: +53.06%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $6.76
Upside: -26.04%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $27.14
Upside: +47.41%
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $0.9035
Upside: -
Feb 23, 2026
Maintained: Buy
Price Target: n/a
Current: $101.25
Upside: -
Dec 16, 2025
Maintained: Buy
Price Target: $12
Current: $6.13
Upside: +95.76%
Dec 9, 2025
Maintained: Buy
Price Target: n/a
Current: $2.29
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: n/a
Current: $4.32
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $20.24
Upside: n/a
Apr 25, 2025
Maintained: Buy
Price Target: n/a
Current: $13.89
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: n/a
Current: $25.96
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.34
Upside: n/a
Aug 7, 2024
Maintained: Buy
Price Target: n/a
Current: $1.97
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $3.03
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: n/a
Current: $11.78
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $8.77
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $13.59
Upside: n/a
Jan 18, 2019
Maintained: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $71.60
Upside: n/a
Feb 27, 2018
Maintained: Buy
Price Target: $19
Current: $4.20
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $78.78
Upside: n/a